- Home
- LGO vs RLMD Comparison
LGO vs RLMD Comparison
Compare LGO & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGO
- RLMD
- Stock Information
- Founded
- LGO 1988
- RLMD 2004
- Country
- LGO Canada
- RLMD United States
- Employees
- LGO N/A
- RLMD N/A
- Industry
- LGO
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- LGO
- RLMD Health Care
- Exchange
- LGO Nasdaq
- RLMD Nasdaq
- Market Cap
- LGO 134.0M
- RLMD 110.6M
- IPO Year
- LGO 2007
- RLMD N/A
- Fundamental
- Price
- LGO $1.70
- RLMD $0.36
- Analyst Decision
- LGO Strong Buy
- RLMD Hold
- Analyst Count
- LGO 1
- RLMD 4
- Target Price
- LGO $4.20
- RLMD $4.25
- AVG Volume (30 Days)
- LGO 143.9K
- RLMD 2.1M
- Earning Date
- LGO 11-12-2024
- RLMD 11-07-2024
- Dividend Yield
- LGO N/A
- RLMD N/A
- EPS Growth
- LGO N/A
- RLMD N/A
- EPS
- LGO N/A
- RLMD N/A
- Revenue
- LGO $144,822,000.00
- RLMD N/A
- Revenue This Year
- LGO N/A
- RLMD N/A
- Revenue Next Year
- LGO $37.73
- RLMD N/A
- P/E Ratio
- LGO N/A
- RLMD N/A
- Revenue Growth
- LGO N/A
- RLMD N/A
- 52 Week Low
- LGO $1.38
- RLMD $0.34
- 52 Week High
- LGO $2.84
- RLMD $7.22
- Technical
- Relative Strength Index (RSI)
- LGO 34.97
- RLMD 17.00
- Support Level
- LGO $2.03
- RLMD $0.34
- Resistance Level
- LGO $1.84
- RLMD $0.40
- Average True Range (ATR)
- LGO 0.12
- RLMD 0.09
- MACD
- LGO -0.04
- RLMD -0.02
- Stochastic Oscillator
- LGO 9.30
- RLMD 0.72
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The Company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The Company has six operating segments: sales & trading wich generates key revenue, mine properties, corporate, exploration and evaluation properties, Largo Clean Energy, and Largo Physical Vanadium.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.